Page last updated: 2024-10-30

loratadine and B16 Melanoma

loratadine has been researched along with B16 Melanoma in 2 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandes, LJ1
Warrington, RC1
Arron, RJ1
Bogdanovic, RP1
Fang, W1
Queen, GM1
Stein, DA1
Tong, J1
Zaborniak, CL1
LaBella, FS1
Robinson, A1

Other Studies

2 other studies available for loratadine and B16 Melanoma

ArticleYear
Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlates.
    Journal of the National Cancer Institute, 1994, May-18, Volume: 86, Issue:10

    Topics: Animals; Astemizole; Carcinogens; Cetirizine; Doxylamine; Female; Histamine H1 Antagonists; Hydroxyz

1994
More questions than answers: antihistamines' link to cancer.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1994, Sep-15, Volume: 151, Issue:6

    Topics: Animals; Astemizole; Canada; Dose-Response Relationship, Drug; Drug Industry; Fibrosarcoma; Histamin

1994